{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:04:46Z","timestamp":1789833886948,"version":"4.0.1"},"reference-count":32,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.1210\/jc.2009-2133","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T23:54:46Z","timestamp":1267487686000},"page":"2367-2375","source":"Crossref","is-referenced-by-count":35,"title":["Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?"],"prefix":"10.1210","volume":"95","author":[{"given":"Meena","family":"Asmar","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences (M.A., M.B., J.J.H.), University of Copenhagen, DK-2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bache","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences (M.A., M.B., J.J.H.), University of Copenhagen, DK-2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[{"name":"Internal Medicine F (F.K.K.), Gentofte Hospital, DK-2900 Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (M.A., S.M.), Hvidovre Hospital, DK-2650 Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences (M.A., M.B., J.J.H.), University of Copenhagen, DK-2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113422273600_R1","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1152\/ajpendo.00545.2003","article-title":"Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans","volume":"287","author":"Holst","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113422273600_R2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113422273600_R3","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/endo-123-4-2009","article-title":"Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach","volume":"123","author":"Orskov","year":"1988","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113422273600_R4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1043-2760(99)00157-5","article-title":"Glucagon-like peptide 1(GLP-1): an intestinal hormone signalling nutritional abundance, with an unusual therapeutic potential","volume":"10","author":"Holst","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113422273600_R5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113422273600_R6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"Gutzwiller","year":"1999","journal-title":"Gut"},{"key":"key\n\t\t\t\t2019041113422273600_R7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","article-title":"Amylin concentrations and glucose control","volume":"339","author":"Koda","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113422273600_R8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113422273600_R9","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key\n\t\t\t\t2019041113422273600_R10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t2019041113422273600_R11","first-page":"A82","article-title":"Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over study","volume":"53","author":"Chapman","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113422273600_R12","first-page":"A232","article-title":"Pramlintide therapy in addition to insulin in type 1 diabetes: effect on metabolic control after 6 months","volume":"42","author":"Fineman","year":"1999","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113422273600_R13","first-page":"A232","article-title":"Pramlintide therapy in addition to insulin in type 2 diabetes: effect on metabolic control after 6 months","volume":"42","author":"Gottlieb","year":"1999","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113422273600_R14","first-page":"A109","article-title":"Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 1 diabetes during treatment for 52 weeks","volume":"49","author":"Gottlieb","year":"2000","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113422273600_R15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","article-title":"Amyloid fibril formation from full-length and fragments of amylin","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2019041113422273600_R16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(00)01287-4","article-title":"Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils","volume":"470","author":"Higham","year":"2000","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t2019041113422273600_R17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","article-title":"Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus","volume":"183","author":"Betsholtz","year":"1989","journal-title":"Exp Cell Res"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113422273600_R18","first-page":"235A","article-title":"The selection of pramlintide for clinical evaluation","volume":"45","author":"Janes","year":"1996","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113422273600_R19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199411243312107","article-title":"Mechanisms of disease\u2014the pathogenesis of insulin-dependent diabetes-mellitus","volume":"331","author":"Atkinson","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113422273600_R20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t2019041113422273600_R21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","author":"Naiki","year":"1989","journal-title":"Anal Biochem"},{"key":"key\n\t\t\t\t2019041113422273600_R22","first-page":"768","article-title":"Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T","volume":"62","author":"Naiki","year":"1990","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t2019041113422273600_R23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s001340050325","article-title":"A model of gastric emptying using paracetamol absorption in intensive care patients","volume":"23","author":"Tarling","year":"1997","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019041113422273600_R24","first-page":"3575","article-title":"Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide","volume":"85","author":"Deacon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113422273600_R25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/bj2070381","article-title":"Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin","volume":"207","author":"Holst","year":"1982","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t2019041113422273600_R26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000201151","article-title":"Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy","volume":"55","author":"Andreasen","year":"1994","journal-title":"Digestion"},{"key":"key\n\t\t\t\t2019041113422273600_R27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","article-title":"Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients","volume":"36","author":"Nauck","year":"1993","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113422273600_R28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113422273600_R29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113422273600_R30","first-page":"A179","article-title":"Effect of amylin on intestinal glucose transport","volume":"43","author":"Young","year":"2000","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113422273600_R31","doi-asserted-by":"crossref","first-page":"E873","DOI":"10.1152\/ajpendo.00452.2001","article-title":"GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion","volume":"282","author":"Deacon","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113422273600_R32","doi-asserted-by":"crossref","first-page":"E1118","DOI":"10.1152\/ajpendo.00576.2005","article-title":"The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans","volume":"290","author":"Meier","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/5\/2367\/9069133\/jcem2367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T10:36:27Z","timestamp":1558866987000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/5\/2367\/2597299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-2133","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}